USA Equities Corp. Introduces AllergiQT?? Quick Test, Further Expanding Market Presence
November 29, 2021 at 08:00 am
Share
USA Equities Corp. introduced its proprietary AllergiQT? - Quick Test focused on the allergy testing market and targeting independent primary care physicians in the United States. The AllergiQT?-Quick Test is an FDA-cleared, time-efficient, and easily administered skin test for environmental and food allergens. The test is designed to be conducted in a primary care provider office and focuses on twenty of the most common allergic and asthmatic allergen triggers and symptoms. Once an offending allergen is identified, the physician can either prescribe subcutaneous injections, administered during subsequent office visits, or sublingual immunotherapy drops for home based treatment. For physicians, the AllergiQT? product can generate additional revenue through physician reimbursement codes accepted by commercial payors, Medicare and Medicaid, while saving time and maximizing the value of face-to-face office visits. From a patient perspective, allergies due to their inflammatory effects, are implicated in other chronic diseases including asthma, COPD, hypertension, coronary artery disease, and emotional conditions such as stress and anxiety. By identifying allergies earlier in the process, physicians can offer solutions that both relieve and stem allergic reactions and, in some instances, act as a preventative to other diseases. Key aspects of the AllergiQT?-Quick Test product include: Targeting non-allergy specialists in primary care settings; The AllergiQT? test is minimally-invasive and can be easily administered during an office visit. Two multiple head applicators without needles are placed on the forearms of a patient during a routine physical examination; The twenty-allergen allergy skin test kit includes environmental and food plus environmental options; Within 15 minutes, if the patient has any reactions, the physician can easily identify the allergen and offer a prescription remedy to begin treatment during the same office visit, there are no waiting for lab test results; AllergiQT? quick test results offer physicians the ability to employ evidence-based plans that treat the cause of allergies instead of the symptoms by providing prescription medicines formulated through its associated, accredited specialty pharmacy.
QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.